Search

How can companies make their mark as the biosimilar market continues to grow?

Five members of The Medicine Maker’s 2022 Power List share their thoughts on how the pharma industry can improve.

AI is making waves across industries, but what impact will it have on pharmaceutical marketing?

Why pharma and the high tech sector should band together for the sake of innovation.

Change is in the air for drug pricing in the US after the Senate passes the Inflation Reduction Act.

As we transition into the endemic phase of the pandemic, companies will have to consider how their mRNA products will be housed and stored.

What are the best locations for a pharma business to base entities when it comes to operating costs?

How can an understanding of the relationships between molecular structure and physicochemical data streamline drug discovery and development?

How will pharma companies navigate America’s new abortion laws?

In our third C+G Champions installment, we ask industry leaders in the cell and gene field about accessibility for the many